$100+ Billion spent on myriad of acquisitions across Pharma and Biotech industries in H1 2018
Lloyd Price
JULY 5, 2018
For many biotech companies, mergers and acquisitions have become a cornerstone in building a robust pipeline that can ensure positive growth for years to come. Morgan Healthcare Conference when Celgene acquired San Diego-based Impact Biomedicines and its JAK inhibitor program targeting myelofibrosis. The Swiss company held a 36.5
40 
Let's personalize your content